FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283691404> ?p ?o ?g. }

• W4283691404 endingPage "1606" @default.
• W4283691404 startingPage "1606.1" @default.
• W4283691404 abstract "Background Psoriatic arthritis (PA) is a complex, systemic, chronic inflammatory condition with substantial multisystemic detrimental effects on patients’ health status. In PA patients there was reported increased anxiety occurrence when compared to general population, even if specific predictors are not defined yet [1]. Objectives To characterize disease-related predictors of anxiety in patients with PA. Methods Cross-sectional study with prospective, successive inclusion of patients fulfilling the CASPAR (ClASsification criteria for Psoriatic ARthritis) classification criteria for PA. Anxiety level was assessed using the General Anxiety Disorder-7 (GAD-7) with a cut-off of 10 points as previous defined [2]. Moreover, disease activity status for PA was defined using also validated scores, namely the Disease Activity Index for Psoriatic Arthritis (DAPSA), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Ankylosing Spondylitis Disease Activity Score (ASDAS), cutaneous involvement by the Psoriasis Area Severity Index (PASI), and comorbidities by Psoriatic arthritis comorbidity index (PsACI). Results 56 PA patients were included, 29 (51.8%) males, with mean±SD age at inclusion of 54.1±13.2years. Regarding the tools for disease activity assessment, the probability of impact over a high anxiety level as estimated by area under curve (AUC) was high (> 0.800) for BASDAI [AUC(95%CI) 0.859 (0.738-0.979)], especially in relation with the last 3 items about inflammation of other than neck, back or hip joints and morning stiffness (see Figure 1). Figure 1. The Area Under the curve of the Receiver Operating Characteristic (AUROC) for high anxiety level (GAD-7 > 10) In bivariate analysis, we found a significant difference regarding a higher anxiety level as assessed by GAD-7 for female gender (28.6% vs. 78.9%, p=0.001), concomitance of peripheral and axial articular involvement (25.7% vs. 52.6%, p=0.034), DAPSA (14.8 (7.1; 22.8) vs. 24.6 (12.2; 36.8), p=0.035), BASDAI (3.1 (1.3; 4.1) vs. 7.1 (5.0; 8.0), p<0.001), and ASDAS-CRP (2.5 (1.1; 3.7) vs. 3.5 (2.7; 4.0), p=0.038), but not for the other parameters search, namely age, smoking, alcohol intake, home settle (urban/ rural, living alone, kids), disease duration, HLA-B27 status, PASI, PsACI, Patient (PtGA) or Physician (PGA) Global Assessment, ongoing corticosteroid treatment, or inflammation status (ESR, CRP). In multivariate analysis, the PA disease-related predictor for increased anxiety was the auto-evaluation by BASDAI, OR (95%CI) 1.844 (1.198 - 2.839) (see Table 1). Table 1. Independent predictors for anxiety in psoriatic arthritis patients Parameter 95% CI p-value lower upper Gender, F/M (%F) 0.106 0.023 0.498 0.004 Articular axial and peripheric, Y/N (%Y) 0.289 0.055 1.503 0.140 DAPSA 1.017 0.973 1.063 0.460 BASDAI 1.844 1.198 2.839 0.005 ASDAS-CRP 1.312 0.877 1.964 0.186 Conclusion Therefore, higher BASDAI results were associated with increased anxiety in PA and so such results should raise awareness about the need of search for associated anxiety disorders. On the contrary, the extension of the cutaneous involvement, the systemic inflammation level or the comorbidities degree were not identified as predictors for the anxiety occurrence. References [1]Zusman EZ, Howren AM, Park JYE, et al. Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2020; 50 :1481–8. doi:10.1016/j.semarthrit.2020.02.001 [2]Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166 :1092 7.doi:10.1001/archinte.166.10.1092 Disclosure of Interests None declared" @default.
• W4283691404 created "2022-06-30" @default.
• W4283691404 creator A5013951002 @default.
• W4283691404 creator A5025230553 @default.
• W4283691404 creator A5028922632 @default.
• W4283691404 creator A5054820817 @default.
• W4283691404 creator A5068288430 @default.
• W4283691404 creator A5072895898 @default.
• W4283691404 creator A5090546688 @default.
• W4283691404 date "2022-05-23" @default.
• W4283691404 modified "2023-09-26" @default.
• W4283691404 title "AB0955 Disease activity impact over the anxiety level in patients with psoriatic arthritis" @default.
• W4283691404 doi "https://doi.org/10.1136/annrheumdis-2022-eular.4611" @default.
• W4283691404 hasPublicationYear "2022" @default.
• W4283691404 type Work @default.
• W4283691404 citedByCount "0" @default.
• W4283691404 crossrefType "journal-article" @default.
• W4283691404 hasAuthorship W4283691404A5013951002 @default.
• W4283691404 hasAuthorship W4283691404A5025230553 @default.
• W4283691404 hasAuthorship W4283691404A5028922632 @default.
• W4283691404 hasAuthorship W4283691404A5054820817 @default.
• W4283691404 hasAuthorship W4283691404A5068288430 @default.
• W4283691404 hasAuthorship W4283691404A5072895898 @default.
• W4283691404 hasAuthorship W4283691404A5090546688 @default.
• W4283691404 hasBestOaLocation W42836914041 @default.
• W4283691404 hasConcept C118552586 @default.
• W4283691404 hasConcept C126322002 @default.
• W4283691404 hasConcept C16005928 @default.
• W4283691404 hasConcept C1862650 @default.
• W4283691404 hasConcept C2776260265 @default.
• W4283691404 hasConcept C2777011040 @default.
• W4283691404 hasConcept C2777077863 @default.
• W4283691404 hasConcept C2777402515 @default.
• W4283691404 hasConcept C2777453003 @default.
• W4283691404 hasConcept C2779159551 @default.
• W4283691404 hasConcept C2780564577 @default.
• W4283691404 hasConcept C2908647359 @default.
• W4283691404 hasConcept C558461103 @default.
• W4283691404 hasConcept C58471807 @default.
• W4283691404 hasConcept C71924100 @default.
• W4283691404 hasConcept C99454951 @default.
• W4283691404 hasConceptScore W4283691404C118552586 @default.
• W4283691404 hasConceptScore W4283691404C126322002 @default.
• W4283691404 hasConceptScore W4283691404C16005928 @default.
• W4283691404 hasConceptScore W4283691404C1862650 @default.
• W4283691404 hasConceptScore W4283691404C2776260265 @default.
• W4283691404 hasConceptScore W4283691404C2777011040 @default.
• W4283691404 hasConceptScore W4283691404C2777077863 @default.
• W4283691404 hasConceptScore W4283691404C2777402515 @default.
• W4283691404 hasConceptScore W4283691404C2777453003 @default.
• W4283691404 hasConceptScore W4283691404C2779159551 @default.
• W4283691404 hasConceptScore W4283691404C2780564577 @default.
• W4283691404 hasConceptScore W4283691404C2908647359 @default.
• W4283691404 hasConceptScore W4283691404C558461103 @default.
• W4283691404 hasConceptScore W4283691404C58471807 @default.
• W4283691404 hasConceptScore W4283691404C71924100 @default.
• W4283691404 hasConceptScore W4283691404C99454951 @default.
• W4283691404 hasIssue "Suppl 1" @default.
• W4283691404 hasLocation W42836914041 @default.
• W4283691404 hasOpenAccess W4283691404 @default.
• W4283691404 hasPrimaryLocation W42836914041 @default.
• W4283691404 hasRelatedWork W1820449389 @default.
• W4283691404 hasRelatedWork W2056519404 @default.
• W4283691404 hasRelatedWork W2144181824 @default.
• W4283691404 hasRelatedWork W2551838351 @default.
• W4283691404 hasRelatedWork W2943631570 @default.
• W4283691404 hasRelatedWork W3165248813 @default.
• W4283691404 hasRelatedWork W3210457022 @default.
• W4283691404 hasRelatedWork W4283692022 @default.
• W4283691404 hasRelatedWork W4285613639 @default.
• W4283691404 hasRelatedWork W2547329519 @default.
• W4283691404 hasVolume "81" @default.
• W4283691404 isParatext "false" @default.
• W4283691404 isRetracted "false" @default.
• W4283691404 workType "article" @default.